Your browser doesn't support javascript.
loading
miR-224-5p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway.
Liu, Yifan; Ruan, Hongru; Lu, Feng; Peng, Huiyong; Luan, Wenkang.
Afiliação
  • Liu Y; Department of Plastic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Ruan H; Department of Plastic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Lu F; Department of Plastic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Peng H; Department of Laboratory Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Medical School of Nanjing Medical University, Zhenjiang, Jiangsu, China; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health,
  • Luan W; Department of Plastic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: luanwenkang@126.com.
Pathol Res Pract ; 249: 154772, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37611431
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / MicroRNAs / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Pathol Res Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / MicroRNAs / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Pathol Res Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China